“Rho Kinase Inhibitors for Glaucoma and Optic Neuropathy Treatment: Enzyme Activity, Cell Effects, IOP-Lowering and Neuroprotection Perspectives”. Open Access Journal of Ophthalmology, vol. 7, no. 1, Jan. 2022, pp. 1-23, https://doi.org/10.23880/oajo-16000233.